Zenas BioPharma, Inc.
ZBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $319,742 | $56,857 | $67,209 |
| Short-Term Investments | $31,024 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $5,157 | $2,947 | $1,235 |
| Total Curr. Assets | $355,923 | $59,804 | $68,444 |
| Property Plant & Equip (Net) | $1,189 | $1,014 | $1,801 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $12,856 | $7,362 | $4,334 |
| Total NC Assets | $14,045 | $8,376 | $6,135 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $369,968 | $68,180 | $74,579 |
| Liabilities | – | – | – |
| Payables | $17,136 | $5,396 | $5,815 |
| Short-Term Debt | $785 | $556 | $715 |
| Tax Payable | $211 | $301 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $39,160 | $17,005 | $19,437 |
| Total Curr. Liab. | $57,292 | $23,258 | $25,967 |
| LT Debt | $218 | $20,557 | $812 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $250,086 | $240,086 |
| Total NC Liab. | $218 | $270,643 | $240,898 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $1,003 | $813 | $1,527 |
| Total Liabilities | $57,510 | $293,901 | $266,865 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $4 | $0 | $0 |
| Retained Earnings | -$387,391 | -$230,403 | -$193,279 |
| AOCI | $194 | $37 | -$41 |
| Other Equity | $699,651 | $4,645 | $1,034 |
| Total Equity | $312,458 | -$225,721 | -$192,286 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $369,968 | $68,180 | $74,579 |
| Net Debt | -$318,739 | -$35,744 | -$65,682 |